查看购物车
  • Traditional Chinese
  • English
  • Japanese
医疗保健市场中的人工智慧 (AI)：全球按产品、功能、应用、部署模式、工具、最终用户和地区划分 - 预测至 2030 年
市场调查报告书
商品编码
1728616

医疗保健市场中的人工智慧 (AI)：全球按产品、功能、应用、部署模式、工具、最终用户和地区划分 - 预测至 2030 年

Artificial Intelligence(AI) in Healthcare Market by Offering(Integrated), Function(Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application(Clinical), End User(Hospitals), Region-Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 713 Pages | 订单完成后即时交付

价格

预计全球医疗保健人工智慧 (AI) 市场规模将从 2025 年的 216.6 亿美元增长到 2030 年的 1,106.1 亿美元，预测期内的复合年增长率为 38.6%。

由于公共和私人组织的投资和资金筹措不断增加、医疗保健行业对人工智慧的快速应用以及对开发人类感知人工智慧系统的日益关注，预计市场将会成长。由于医疗保健人员与患者人口比例不平衡，市场正在成长，这推动了对改善服务的需求。然而，新兴国家IT基础设施不足以及不愿采用基于人工智慧的医疗保健解决方案预计将对市场成长构成挑战。

研究范围
调查年份 2024-2030
基准年 2024
预测期 2024-2030
对价单位 金额（十亿美元）
部分 按产品、按功能、按用途、按部署模式、按工具、按最终用户、按地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

医疗保健领域的AI市场分为三种部署模式：内部部署、云端基础和混合模式。云端基础的模型因其扩充性、成本效益和易于存取而占据最大的份额。云端基础的模型促进即时数据处理和协作。其无缝整合、安全的资料储存和快速部署使其特别适合医疗保健提供者和付款人。在维持高品质标准的同时提供更快、更可靠的照护。云端基础的人工智慧解决方案因其成本效益、扩充性和对远端存取的支援而变得越来越受欢迎。这些解决方案实现了无缝整合和即时分析。远端医疗的兴起和医疗保健IT基础设施的进步进一步推动了对云端基础的模型的需求。

根据最终用户，医疗保健市场中的人工智慧 (AI) 分为医院和诊所、门诊手术中心、居家医疗机构和辅助生活设施、诊断和影像中心、药房和其他医疗保健提供者。医院和诊所部门占据医疗保健领域人工智慧 (AI) 市场的最大份额。这是由个人化医疗、精准诊断和手术计划的需求不断增长、微创手术的增加以及与现有系统互通性的要求所推动的。基于人工智慧的医疗保健解决方案将提高诊断准确性、简化业务并使医院和诊所的护理个性化。自动执行管理业务、预测患者结果并透过即时数据分析做出更快的决策。人工智慧还支援远端监控，透过最大限度地减少不必要的治疗来优化资源并降低成本。人工智慧可以透过虚拟助理提高病患参与度，透过侦测诈欺来增强安全性，并使医疗保健更有效率、便利且具有成本效益。

医疗保健领域的人工智慧 (AI) 市场细分为北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。预计亚太地区将在预测期内实现最高成长。在人口变化、技术进步和创新投资增加等因素的推动下，亚太地区医疗保健领域人工智慧技术的采用正在显着增加。亚太地区老龄人口不断增长是关键因素，65岁及以上人口比例显着增加。根据联合国《2020年世界人口老化报告》，预计到2050年，全球该年龄层人口数量将从2020年的7.27亿翻一番，达到15亿，其中东亚和东南亚将占很大比例。

本报告研究了全球医疗保健人工智慧 (AI) 市场，并根据产品、功能、应用、部署模式、工具、最终用户、区域趋势和市场参与者概况对其进行细分。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章市场概述

  • 介绍
  • 市场动态
  • 影响客户业务的趋势/中断
  • 技术分析
  • 产业趋势
  • 定价分析
  • 价值链分析
  • 生态系分析
  • 专利分析
  • 大型会议及活动
  • 案例研究分析
  • 监管状况
  • 波特五力分析
  • 主要相关人员和采购标准
  • 最终用户分析
  • 医疗保健经营模式中的人工智慧
  • 投资金筹措场景
  • 生成式人工智慧将如何影响医疗保健领域的人工智慧

6. 2025年美国关税的影响－概述

  • 介绍
  • 主要关税税率
  • 价格影响分析
  • 对国家的影响
  • 对终端产业的影响

7. 医疗保健市场中的人工智慧（AI）

  • 介绍
  • 整合解决方案
  • 利基/点解决方案
  • 人工智慧技术
  • 服务

第八章 医疗保健领域的人工智慧 (AI) 市场（按功能划分）

  • 介绍
  • 诊断和早期检测
  • 治疗计划和个性化
  • 病人参与和远端监控
  • 治疗后监测和生存护理
  • 药局管理
  • 数据管理与分析
  • 行政

第九章 医疗保健领域的人工智慧 (AI) 市场（按应用）

  • 介绍
  • 临床
  • 非临床

第 10 章医疗保健领域的人工智慧 (AI) 市场（按部署模式）

  • 介绍
  • 本地模型
  • 云端基础的模型
  • 混合模式

第 11 章 医疗保健领域的人工智慧 (AI) 市场（按工具）

  • 介绍
  • 机器学习
  • 自然语言处理（NLP）
  • 情境感知计算
  • 人工智慧世代
  • 电脑视觉
  • 影像分析

第 12 章医疗保健领域的人工智慧 (AI) 市场（按最终用户划分）

  • 介绍
  • 医疗保健提供者
  • 医疗保健付款人
  • 病人
  • 其他的

第十三章 医疗保健市场中的人工智慧（AI），按地区

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 中国
    • 日本
    • 印度
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 中东和非洲宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十四章竞争格局

  • 介绍
  • 主要参与企业的策略/优势
  • 2020-2024年收益分析
  • 2024年市场占有率分析
  • 公司估值矩阵：2024 年主要参与企业
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 估值和财务指标
  • 品牌/产品比较
  • 竞争场景

第十五章 公司简介

  • 主要参与企业
    • KONINKLIJKE PHILIPS NV
    • MICROSOFT CORPORATION
    • NVIDIA CORPORATION
    • SIEMENS HEALTHINEERS AG
    • GE HEALTHCARE
    • EPIC SYSTEMS CORPORATION
    • ORACLE CORPORATION
    • VERADIGM INC.
    • AMAZON WEB SERVICES, INC.
    • MERATIVE
    • IBM
    • MEDTRONIC
    • GOOGLE
    • SOPHIA GENETICS
    • JOHNSON & JOHNSON SERVICES, INC.
    • TEMPUS AI, INC.
    • CONCERTAI
    • SOLVENTUM CORPORATION
    • COGNIZANT
    • VIZ.AI, INC.
    • RIVERAIN TECHNOLOGIES
  • 其他公司
    • QVENTUS
    • QURE.AI
    • ATOMWISE INC.
    • ENLITIC
    • SEGMED

第十六章 附录

Product Code: HIT 9226

The global Artificial Intelligence (AI) in healthcare market is projected to reach USD 110.61 billion by 2030 from USD 21.66 billion in 2025, at a CAGR of 38.6% during the forecast period. The market is expected to grow due to the growing investments & funding by public-private organizations, the fast proliferation of AI in the healthcare industry, and the rising focus on developing human-aware AI systems. The market has experienced growth due to increasing demand for enhanced services due to an unequal ratio between the healthcare workforce and patient numbers. However, inadequate IT infrastructure and unwillingness to adopt AI-based healthcare solutions in emerging economies are estimated to pose a challenge to market growth.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsOffering, Function, Application, Deployment, Tools, End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

By deployment, the cloud-based segment is expected to register the highest growth during the forecast period.

The AI in healthcare market is categorized into three deployment models: on-premise, cloud-based, and hybrid models. The cloud-based models segment holds the largest share due to the scalability, cost-effectiveness, and accessibility of these models. Cloud-based models facilitate real-time data processing and collaboration. They allow for seamless integration, secure data storage, and rapid deployment, making them particularly suitable for healthcare providers and payers. They provide faster, more reliable care while maintaining high-quality standards. Cloud-based AI solutions are becoming increasingly popular due to their cost-effectiveness, scalability, and support for remote access. These solutions enable seamless integration and real-time analytics. The growing adoption of telehealth and advancements in healthcare IT infrastructure further drive the demand for cloud-based models.

By end user, the hospitals & clinics segment dominated the market in the Artificial Intelligence (AI) in healthcare market for healthcare providers in 2024.

By end user, Artificial Intelligence (AI) in healthcare market is segmented into hospitals & clinics, ambulatory surgical centers, home healthcare agencies & assisted living facilities, diagnostic & imaging centers, pharmacies, and other healthcare providers. The hospitals & clinics segment accounted for the largest share of the Artificial Intelligence (AI) in healthcare market. This is attributed to the increasing demand for personalized medicines, precise diagnostics & surgical planning, growth in minimally-invasive procedures, and the requirement for interoperability with existing systems. AI-based healthcare solutions enhance diagnostic accuracy, streamline operations, and personalize care in hospitals and clinics. They automate administrative tasks, predict patient outcomes, and enable faster decision-making with real-time data analysis. AI also supports remote monitoring, optimizes resources, and reduces costs by minimizing unnecessary treatments. AI improves patient engagement through virtual assistants and enhances security by detecting fraud, making healthcare more efficient, accessible, and cost-effective.

Asia Pacific is expected to register the highest growth during the forecast period.

The Artificial Intelligence (AI) in healthcare market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register the highest growth during the forecast period. The Asia Pacific (APAC) region is experiencing substantial growth in the adoption of AI technologies within the healthcare sector, driven by a combination of demographic shifts, technological advancements, and increased investments in innovation. The rising elderly population in the Asia Pacific is a key factor, with the proportion of individuals aged 65 years and above increasing significantly. According to the UN's World Population Aging 2020 report, the global population in this age group is expected to double from 727 million in 2020 to 1.5 billion by 2050, with Eastern and Southeastern Asia contributing a large share of this growth.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
  • By Designation - Directors: 30%, Manager: 34%, and Others: 36%
  • By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

Key Players

The prominent players operating in the Artificial Intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), SOPHiA GENETICS (US), Riverian Technologies (US), Terarecon (ConcertAI) (US), Solventum Corporation (US), Tempus (US), Viz.ai (US). These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the Artificial Intelligence (AI) in healthcare market.

Research Coverage

The report analyzes the Artificial Intelligence (AI) in healthcare market and aims to estimate the market size and future growth potential of various market segments based on offering, solution type, imaging modality, application, end user, and region. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges in the market stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total Artificial Intelligence (AI) in healthcare market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a higher market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of key drivers (exponential growth in data volume and complexity due to surging adoption of digital technologies, significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases, rapid proliferation of AI in healthcare sector, growing need for improvised healthcare services, growing need for early detection and diagnosis, restraints (reluctance among medical practitioners to adopt AI-based technologies, shortage of skilled AI professionals handling AI-powered solutions, lack of standardized frameworks for AI and ML technologies), opportunities (increasing use of AI-powered solutions in elderly care, increasing focus on developing human-aware AI systems, strategic partnerships and collaborations among healthcare companies and AI technology providers), challenges (inaccurate predictions due to scarcity of high-quality healthcare data, concerns regarding data privacy, lack of interoperability between AI solutions offered by different vendors) are factors contributing the growth of the Artificial Intelligence (AI) in healthcare market
  • Product Development/Innovation: Detailed insights into upcoming trends, research & development activities, and software launches in the Artificial Intelligence (AI) in healthcare market
  • Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region
  • Market Diversification: Exhaustive information about software portfolios, growing geographies, recent developments, and investments in the Artificial Intelligence (AI) in healthcare market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Artificial Intelligence (AI) in healthcare market, such as Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US)

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 AI IN HEALTHCARE MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: AI IN HEALTHCARE, BY OFFERING AND COUNTRY
  • 4.3 AI IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 AI IN HEALTHCARE MARKET: REGIONAL MIX
  • 4.5 AI IN HEALTHCARE: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increase in need for early detection and diagnosis
      • 5.2.1.2 Exponential growth in data volume and complexity due to surging adoption of digital technologies
      • 5.2.1.3 Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases
      • 5.2.1.4 Rapid proliferation of AI in healthcare sector
      • 5.2.1.5 Growth in need for improvised healthcare services
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Reluctance among medical practitioners to adopt AI-based technologies
      • 5.2.2.2 Shortage of skilled AI professionals handling AI-powered solutions
      • 5.2.2.3 Lack of standardized frameworks for AI and ML technologies
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing use of AI-powered solutions in elderly care
      • 5.2.3.2 Increase in focus on developing human-aware AI systems
      • 5.2.3.3 Strategic partnerships and collaborations among healthcare companies and AI technology providers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Inaccurate predictions due to scarcity of high-quality healthcare data
      • 5.2.4.2 Concerns regarding data privacy
      • 5.2.4.3 Lack of interoperability between AI solutions offered by different vendors
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Machine learning (ML) and deep learning
      • 5.4.1.2 Natural language processing (NLP)
      • 5.4.1.3 Computer vision (CV)
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Cloud computing
      • 5.4.2.2 Digital twins
      • 5.4.2.3 Robotic process automation (RPA)
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Blockchain
      • 5.4.3.2 Augmented and virtual reality (AR/VR)
      • 5.4.3.3 Internet of things (IoT)
  • 5.5 INDUSTRY TRENDS
    • 5.5.1 SHIFT TOWARD PERSONALIZED MEDICINE
    • 5.5.2 AI IN DIAGNOSTICS AND IMAGING
  • 5.6 PRICING ANALYSIS
    • 5.6.1 INDICATIVE PRICING OF AI IN HEALTHCARE SOFTWARE, BY DEPLOYMENT MODEL (QUALITATIVE)
    • 5.6.2 INDICATIVE PRICING OF AI IN HEALTHCARE SOFTWARE, BY REGION (QUALITATIVE)
  • 5.7 VALUE CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 PATENT ANALYSIS
    • 5.9.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.10 KEY CONFERENCES & EVENTS
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 BIOBEAT LAUNCHED HOME-BASED REMOTE PATIENT MONITORING KIT DURING PEAK WAVE OF COVID-19
    • 5.11.2 MICROSOFT COLLABORATED WITH CLEVELAND CLINIC TO APPLY PREDICTIVE AND ADVANCED ANALYTICS TO IDENTIFY POTENTIAL AT-RISK PATIENTS UNDER ICU CARE
    • 5.11.3 TGEN COLLABORATED WITH INTEL CORPORATION AND DELL TECHNOLOGIES TO ASSIST PHYSICIANS AND RESEARCHERS IN ACCELERATING DIAGNOSIS AND TREATMENT AT LOWER COSTS
    • 5.11.4 GE HEALTHCARE IMPROVED PATIENT OUTCOMES BY REDUCING WORKFLOW PROCESSING TIME USING MEDICAL IMAGING DATA
  • 5.12 REGULATORY LANDSCAPE
    • 5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.12.2 REGULATORY FRAMEWORK
      • 5.12.2.1 North America
      • 5.12.2.2 Europe
      • 5.12.2.3 Asia Pacific
      • 5.12.2.4 Middle East & Africa
      • 5.12.2.5 Latin America
  • 5.13 PORTER'S FIVE FORCES ANALYSIS
    • 5.13.1 THREAT OF NEW ENTRANTS
    • 5.13.2 THREAT OF SUBSTITUTES
    • 5.13.3 BARGAINING POWER OF SUPPLIERS
    • 5.13.4 BARGAINING POWER OF BUYERS
    • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.14.2 BUYING CRITERIA
  • 5.15 END-USER ANALYSIS
    • 5.15.1 UNMET NEEDS
    • 5.15.2 END-USER EXPECTATIONS
  • 5.16 AI IN HEALTHCARE BUSINESS MODELS
    • 5.16.1 SOFTWARE-AS-A-SERVICE (SAAS) MODEL
    • 5.16.2 LICENSING MODEL
    • 5.16.3 REVENUE SHARING/OUTCOME-BASED MODEL
    • 5.16.4 FREEMIUM MODEL
    • 5.16.5 AI-AS-A-SERVICE (AIAAS) MODEL
    • 5.16.6 PARTNERSHIP/REVENUE-SHARING MODEL
    • 5.16.7 HYBRID MODELS
    • 5.16.8 PAY-PER-USE MODELS
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 IMPACT OF GENERATIVE AI ON AI IN HEALTHCARE MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 MARKET POTENTIAL OF GEN AI IN HEALTHCARE
      • 5.18.2.1 Key use cases of Gen AI
    • 5.18.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
      • 5.18.3.1 Eka Care leveraging generative AI for improved health outcomes
    • 5.18.4 INTERCONNECTED AND ADJACENT ECOSYSTEMS
      • 5.18.4.1 AI in healthcare IT
      • 5.18.4.2 AI in medical diagnostics
      • 5.18.4.3 AI in oncology
      • 5.18.4.4 AI in clinical trials
      • 5.18.4.5 AI in drug discovery
    • 5.18.5 USER READINESS & IMPACT ASSESSMENT
      • 5.18.5.1 User readiness
        • 5.18.5.1.1 Healthcare providers
        • 5.18.5.1.2 Healthcare payers
        • 5.18.5.1.3 Patients
      • 5.18.5.2 Impact assessment
        • 5.18.5.2.1 User A: Healthcare providers
          • 5.18.5.2.1.1 Implementation
          • 5.18.5.2.1.2 Impact
        • 5.18.5.2.2 User B: Healthcare payers
          • 5.18.5.2.2.1 Implementation
          • 5.18.5.2.2.2 Impact
        • 5.18.5.2.3 User C: Patients
          • 5.18.5.2.3.1 Implementation
          • 5.18.5.2.3.2 Impact

6 IMPACT OF 2025 US TARIFF - OVERVIEW

  • 6.1 INTRODUCTION
  • 6.2 KEY TARIFF RATES
  • 6.3 PRICE IMPACT ANALYSIS
  • 6.4 IMPACT ON COUNTRY/REGION
    • 6.4.1 US
    • 6.4.2 EUROPE
    • 6.4.3 ASIA PACIFIC
  • 6.5 IMPACT ON END-USE INDUSTRIES

7 AI IN HEALTHCARE MARKET, BY OFFERING

  • 7.1 INTRODUCTION
  • 7.2 INTEGRATED SOLUTIONS
    • 7.2.1 RISE IN WORKFORCE CHALLENGES AND COST PRESSURES TO DRIVE ADOPTION
  • 7.3 NICHE/POINT SOLUTIONS
    • 7.3.1 TARGETED AI SOLUTIONS TRANSFORMING PRECISION CARE AND EFFICIENCY IN HEALTHCARE TO BOOST MARKET
  • 7.4 AI TECHNOLOGIES
    • 7.4.1 ABILITY OF CORE AI TECHNOLOGIES TO DRIVE PRECISION, EFFICIENCY, AND INNOVATION TO SUPPORT MARKET GROWTH
  • 7.5 SERVICES
    • 7.5.1 NEED TO EMPOWER NON-CLINICAL HEALTHCARE OPERATIONS TO FUEL MARKET GROWTH

8 AI IN HEALTHCARE MARKET, BY FUNCTION

  • 8.1 INTRODUCTION
  • 8.2 DIAGNOSIS & EARLY DETECTION
    • 8.2.1 PRE-SCREENING
      • 8.2.1.1 Early detection, better outcomes, and cost-effective care associated with pre-screening to boost market
    • 8.2.2 IVD
      • 8.2.2.1 IVD market, by technology
        • 8.2.2.1.1 Immunoassays
          • 8.2.2.1.1.1 Increase in focus on earlier disease detection & personalized treatment planning to drive market
        • 8.2.2.1.2 Clinical chemistry
          • 8.2.2.1.2.1 Increased demand for precision and personalized medicine and efficient healthcare systems to drive market
        • 8.2.2.1.3 Molecular diagnostics
          • 8.2.2.1.3.1 Improved disease detection, personalized treatments, and enhanced outcomes to fuel growth
      • 8.2.2.2 IVD market, by application
        • 8.2.2.2.1 Image analysis & interpretation
          • 8.2.2.2.1.1 Advantages such as enhanced diagnostic accuracy, faster detection, and improved patient outcomes to support growth
        • 8.2.2.2.2 Biomarker discovery & analysis
          • 8.2.2.2.2.1 Ability of AI-based biomarker discovery to enhance disease detection, prognosis, and personalized treatment to drive adoption
        • 8.2.2.2.3 Other IVD applications
    • 8.2.3 DIAGNOSTIC IMAGING
      • 8.2.3.1 Diagnostic imaging market, by application
        • 8.2.3.1.1 Disease interpretation & report analysis
          • 8.2.3.1.1.1 Ability of AI-driven disease interpretation to accelerate diagnosis, treatment, and outcomes to fuel growth
        • 8.2.3.1.2 Image captioning & annotation
          • 8.2.3.1.2.1 Enhanced diagnostic accuracy, efficiency, and consistency associated with image captioning & annotation to boost market
        • 8.2.3.1.3 Image reconstruction
          • 8.2.3.1.3.1 Improved diagnostic precision, efficiency, and image quality in healthcare to drive market
        • 8.2.3.1.4 Other diagnostic imaging applications
      • 8.2.3.2 Diagnostic imaging market, by modality
        • 8.2.3.2.1 Magnetic resonance imaging (MRI)
          • 8.2.3.2.1.1 Rise in technological advancements to drive adoption of AI in MRI
        • 8.2.3.2.2 Computed tomography (CT)
          • 8.2.3.2.2.1 Increase in availability of cardiac CT devices enabled with AI solutions to drive market
        • 8.2.3.2.3 X-ray imaging
          • 8.2.3.2.3.1 Innovative AI solutions for X-ray imaging by key players to drive market
        • 8.2.3.2.4 Ultrasound
          • 8.2.3.2.4.1 Increase in prevalence of and need for early detection of ovarian cancer to drive market
        • 8.2.3.2.5 Nuclear imaging (PET & SPECT)
          • 8.2.3.2.5.1 Critical role played by PET and SPECT in visualizing metabolic processes to contribute to growth
        • 8.2.3.2.6 Other diagnostic imaging modalities
    • 8.2.4 RISK ASSESSMENT & PATIENT STRATIFICATION
      • 8.2.4.1 AI-driven risk assessment and patient stratification to enhance healthcare efficiency, outcomes, and personalized care
    • 8.2.5 DRUG ALLERGY ALERTING
      • 8.2.5.1 Ability of AI-enhanced drug allergy alerting to improve accuracy and patient safety to boost market
    • 8.2.6 OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS
  • 8.3 TREATMENT PLANNING & PERSONALIZATION
    • 8.3.1 PERSONALIZED TREATMENT PLANNING
      • 8.3.1.1 Precision medicine & genomic analysis
        • 8.3.1.1.1 Advantages such as accurate disease predictions and improved outcomes to drive demand
      • 8.3.1.2 Predictive models for treatment response
        • 8.3.1.2.1 Ability to personalize therapies, improve outcomes, and minimize adverse effects to fuel growth
      • 8.3.1.3 Treatment recommendation systems
        • 8.3.1.3.1 Optimized healthcare delivery associated with treatment recommendation systems to support growth
    • 8.3.2 PHARMACOLOGICAL THERAPY
      • 8.3.2.1 Drug response prediction
        • 8.3.2.1.1 Growth in use of drug response prediction to minimize adverse reactions to drive segment
      • 8.3.2.2 Dosing & administration
        • 8.3.2.2.1 Improved efficacy with highly personalized administration care to fuel adoption
      • 8.3.2.3 Other pharmacological therapy functions
    • 8.3.3 SURGICAL THERAPY
      • 8.3.3.1 Preoperative imaging & 3D modeling
        • 8.3.3.1.1 Enhanced surgical planning and precision to propel market
      • 8.3.3.2 Intraoperative guidance & robotics
        • 8.3.3.2.1 Faster recovery time post surgery to boost adoption
      • 8.3.3.3 Postoperative analysis & recovery
        • 8.3.3.3.1 Reduced complications with real-time monitoring to drive market
    • 8.3.4 RADIATION THERAPY
      • 8.3.4.1 Motion synchronization & auto contouring
        • 8.3.4.1.1 Optimized radiation therapy with motion synchronization & auto contouring to boost market
      • 8.3.4.2 Real-time adaptive treatment delivery
        • 8.3.4.2.1 Reduced side effects with effective adaptive treatment to propel demand
      • 8.3.4.3 Response assessment & quality assurance
        • 8.3.4.3.1 Ability of AI to enhance response assessment and QA to spur growth
      • 8.3.4.4 Other radiation therapy functions
    • 8.3.5 BEHAVIORAL THERAPY & PSYCHOTHERAPY
      • 8.3.5.1 Virtual counseling & chatbots
        • 8.3.5.1.1 Ability to engage patients remotely to drive market demand
      • 8.3.5.2 Progress monitoring & feedback
        • 8.3.5.2.1 Increasing use of smart wearables and mobile health apps to drive market
      • 8.3.5.3 Follow-up & long-term support
        • 8.3.5.3.1 Widespread adoption of telemedicine platforms to drive market demand
    • 8.3.6 IMMUNOTHERAPY
      • 8.3.6.1 Real-time patient data monitoring
        • 8.3.6.1.1 Need for real-time data analysis to make informed decisions to boost market growth
      • 8.3.6.2 Response & side-effect prediction
        • 8.3.6.2.1 Ability to reduce trial-and-error approach in medical treatments to drive segmental growth
      • 8.3.6.3 Relapse prediction & long-term management
        • 8.3.6.3.1 Need for proactive approach for long-term care to fuel market growth
    • 8.3.7 OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS
  • 8.4 PATIENT ENGAGEMENT & REMOTE MONITORING
    • 8.4.1 SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE
      • 8.4.1.1 Rising prevalence of chronic diseases to drive market growth
    • 8.4.2 TELEHEALTH & REMOTE PATIENT MONITORING
      • 8.4.2.1 Ability to monitor and evaluate patients remotely to boost market demand
    • 8.4.3 HEALTHCARE ASSISTANCE ROBOTS
      • 8.4.3.1 Advancements in robotics and artificial intelligence (AI) to boost market demand
    • 8.4.4 MEDICATION REMINDERS
      • 8.4.4.1 Increasing adoption of smartphone applications and IoT devices to surge market demand
    • 8.4.5 PATIENT EDUCATION & EMPOWERMENT
      • 8.4.5.1 Need to improve treatment adherence and enhance self-management to drive market growth
    • 8.4.6 OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS
  • 8.5 POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE
    • 8.5.1 RECURRENCE MONITORING
      • 8.5.1.1 Need to predict recurrence of cancer to drive market
    • 8.5.2 LONG-TERM OUTCOME PREDICTION
      • 8.5.2.1 Ability to predict long-term health outcomes and enhance patient care to drive market
    • 8.5.3 MENTAL HEALTH & SUPPORT SYSTEMS
      • 8.5.3.1 Need to help patients cope with mental strain to drive market
  • 8.6 PHARMACY MANAGEMENT
    • 8.6.1 EPRESCRIBING
      • 8.6.1.1 Need to improve safety and efficiency in prescription to drive market
    • 8.6.2 MEDICATION MANAGEMENT
      • 8.6.2.1 Ability to predict adverse drug reactions by patient data analysis to drive market
    • 8.6.3 PHARMACY AUDIT & ANALYSIS
      • 8.6.3.1 Need for effective and efficient operation of pharmacies to drive market
    • 8.6.4 OTHER PHARMACY MANAGEMENT FUNCTIONS
  • 8.7 DATA MANAGEMENT & ANALYTICS
    • 8.7.1 ABILITY OF DATA MANAGEMENT & ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS MAKE INFORMED DECISIONS TO BOOST MARKET
  • 8.8 ADMINISTRATIVE
    • 8.8.1 PATIENT REGISTRATION & SCHEDULING
      • 8.8.1.1 Need to optimize patient registration process for smoother operations to drive market
    • 8.8.2 PATIENT ELIGIBILITY & AUTHORIZATION
      • 8.8.2.1 Need to reduce administrative burden to drive market
    • 8.8.3 BILLING & CLAIMS MANAGEMENT
      • 8.8.3.1 Need to make billing process more accurate, efficient, and transparent to drive market
    • 8.8.4 WORKFORCE MANAGEMENT
      • 8.8.4.1 Need for effective staff management to drive market
    • 8.8.5 SUPPLY CHAIN & INVENTORY MANAGEMENT
      • 8.8.5.1 Ability to make better procurement decisions to fuel market
    • 8.8.6 COMPLIANCE & DOCUMENTATION
      • 8.8.6.1 Need to reduce manual paperwork and errors to drive market
    • 8.8.7 HEALTHCARE WORKFLOW MANAGEMENT
      • 8.8.7.1 Need to optimize and automate processes within healthcare facilities to drive market
    • 8.8.8 ASSET MANAGEMENT
      • 8.8.8.1 Ability to optimize use and allocation of resources to drive market
    • 8.8.9 CUSTOMER RELATIONSHIP MANAGEMENT
      • 8.8.9.1 Enhancing patient engagement and retention through AI-driven CRM systems to boost market
    • 8.8.10 FRAUD DETECTION & RISK MANAGEMENT
      • 8.8.10.1 Need to enhance security in healthcare systems to drive market demand
    • 8.8.11 CYBERSECURITY
      • 8.8.11.1 Enhancing healthcare cybersecurity with AI-driven threat detection and risk management to fuel growth
    • 8.8.12 OTHER ADMINISTRATIVE FUNCTIONS

9 AI IN HEALTHCARE MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 CLINICAL APPLICATIONS
    • 9.2.1 ABILITY OF AI TO IMPROVE DIAGNOSTICS, TREATMENT, AND PATIENT CARE TO DRIVE MARKET GROWTH
  • 9.3 NON-CLINICAL APPLICATIONS
    • 9.3.1 ABILITY OF AI TO REDUCE ADMINISTRATIVE BURDEN AND ENSURE BETTER RESOURCE ALLOCATION TO FUEL GROWTH

10 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL

  • 10.1 INTRODUCTION
  • 10.2 ON-PREMISE MODELS
    • 10.2.1 ENHANCED DATA SECURITY AND COMPLIANCE TO PROPEL ADOPTION OF ON-PREMISE AI MODELS
  • 10.3 CLOUD-BASED MODELS
    • 10.3.1 SCALABILITY AND AUTOMATION OF CLOUD-BASED AI PLATFORMS TO RESHAPE HEALTHCARE DELIVERY GLOBALLY
  • 10.4 HYBRID MODELS
    • 10.4.1 FLEXIBILITY FOR DIVERSE APPLICATIONS TO BOOST DEMAND FOR HYBRID MODELS

11 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TOOL

  • 11.1 INTRODUCTION
  • 11.2 MACHINE LEARNING
    • 11.2.1 DEEP LEARNING
      • 11.2.1.1 Convolutional neural networks (CNN)
        • 11.2.1.1.1 Growing demand for advance medical imaging and diagnostics to drive market growth
      • 11.2.1.2 Recurrent neural networks (RNN)
        • 11.2.1.2.1 Ability of RNN to enhance predictive analytics in healthcare to boost market
      • 11.2.1.3 Generative adversarial networks (GAN)
        • 11.2.1.3.1 Ability to transform data scarcity and privacy in AI-driven healthcare to drive demand for GAN
      • 11.2.1.4 Graph neural networks (GNN)
        • 11.2.1.4.1 Ability of GNN to revolutionize relational insights in healthcare analytics to fuel growth
      • 11.2.1.5 Other deep learning tools
    • 11.2.2 SUPERVISED LEARNING
      • 11.2.2.1 Need to drive precision and efficiency in healthcare to support adoption of supervised learning tools
    • 11.2.3 REINFORCEMENT LEARNING
      • 11.2.3.1 Wide usage of reinforcement learning models for real-time and adaptive healthcare solutions to support market growth
    • 11.2.4 UNSUPERVISED LEARNING
      • 11.2.4.1 Ability of unsupervised learning to drive innovation in healthcare analytics to propel market
    • 11.2.5 OTHER MACHINE LEARNING TOOLS
  • 11.3 NATURAL LANGUAGE PROCESSING (NLP)
    • 11.3.1 SENTIMENT ANALYSIS
      • 11.3.1.1 Enhanced patient experience and operational insights to spur demand for sentiment analysis
    • 11.3.2 PATTERN & IMAGE RECOGNITION
      • 11.3.2.1 Increased precision in clinical decision-making associated with pattern & image recognition to aid market
    • 11.3.3 AUTO CODING
      • 11.3.3.1 Advantages such as improved medical billing and administrative efficiency to boost market
    • 11.3.4 CLASSIFICATION & CATEGORIZATION
      • 11.3.4.1 Ability of classification & categorization to organize healthcare data for better outcomes to propel market
    • 11.3.5 TEXT ANALYTICS
      • 11.3.5.1 Ability to transform unstructured data into actionable healthcare insights to fuel growth
    • 11.3.6 SPEECH RECOGNITION
      • 11.3.6.1 Improved speech recognition advancing real-time documentation and accessibility to drive demand
  • 11.4 CONTEXT-AWARE COMPUTING
    • 11.4.1 DEVICE CONTEXT
      • 11.4.1.1 Real-time monitoring and decision-making to contribute to market growth
    • 11.4.2 USER CONTEXT
      • 11.4.2.1 Personalized healthcare and adaptive workflows to drive demand
    • 11.4.3 PHYSICAL CONTEXT
      • 11.4.3.1 Location-based services associated with physical context to generate demand
  • 11.5 GENERATIVE AI
    • 11.5.1 ABILITY OF GENERATIVE AI MODELS TO MIMIC DISEASE PROGRESSION TO DRIVE MARKET
  • 11.6 COMPUTER VISION
    • 11.6.1 ABILITY TO DETECT ABNORMALITIES SUCH AS TUMORS TO FUEL ADOPTION
  • 11.7 IMAGE ANALYSIS
    • 11.7.1 NEED TO STREAMLINE DOCUMENT MANAGEMENT TO PROPEL MARKET

12 AI IN HEALTHCARE MARKET, BY END USER

  • 12.1 INTRODUCTION
  • 12.2 HEALTHCARE PROVIDERS
    • 12.2.1 HOSPITALS & CLINICS
      • 12.2.1.1 Growing need to improve profitability of healthcare to drive use of AI-based healthcare solutions in hospitals
    • 12.2.2 AMBULATORY CARE CENTERS
      • 12.2.2.1 Supportive government norms and incentives for HCIT solutions and services to drive market growth
    • 12.2.3 HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES
      • 12.2.3.1 Growing need for long-term home care to drive market growth
    • 12.2.4 DIAGNOSTIC & IMAGING CENTERS
      • 12.2.4.1 Growing burden of various chronic diseases to propel market growth
    • 12.2.5 PHARMACIES
      • 12.2.5.1 Advantages of workflow improvements and error reduction to drive AI-based healthcare solution adoption in pharmacies
    • 12.2.6 OTHER HEALTHCARE PROVIDERS
  • 12.3 HEALTHCARE PAYERS
    • 12.3.1 PUBLIC PAYERS
      • 12.3.1.1 Focus on developing outcome-based payment models to drive demand for payer solutions
    • 12.3.2 PRIVATE PAYERS
      • 12.3.2.1 Possible increases in operational efficiency to boost demand among private payers
  • 12.4 PATIENTS
    • 12.4.1 RISE IN USE OF AI IN MENTAL HEALTH SUPPORT APPLICATIONS THROUGH CHATBOTS AND VIRTUAL THERAPISTS TO BOOST MARKET
  • 12.5 OTHER END USERS

13 AI IN HEALTHCARE MARKET, BY REGION

  • 13.1 INTRODUCTION
  • 13.2 NORTH AMERICA
    • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 13.2.2 US
      • 13.2.2.1 Rising adoption of advanced medical imaging and regulatory support to drive market
    • 13.2.3 CANADA
      • 13.2.3.1 Growing burden of chronic diseases and availability of research grants for AI to drive market growth
  • 13.3 EUROPE
    • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 13.3.2 GERMANY
      • 13.3.2.1 Advanced healthcare system and government efforts to drive growth
    • 13.3.3 UK
      • 13.3.3.1 Government support and new AI platform emergence to boost market
    • 13.3.4 FRANCE
      • 13.3.4.1 Thriving AI ecosystem and strategic partnerships to boost healthcare innovation
    • 13.3.5 ITALY
      • 13.3.5.1 Regulatory reforms, strategic investments, and aging population to propel growth
    • 13.3.6 SPAIN
      • 13.3.6.1 Established network of research centers to propel market
    • 13.3.7 REST OF EUROPE
  • 13.4 ASIA PACIFIC
    • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 13.4.2 CHINA
      • 13.4.2.1 Expanding AI applications in medical imaging and diagnostics to drive market growth
    • 13.4.3 JAPAN
      • 13.4.3.1 Strong healthcare infrastructure to drive uptake of advanced AI
    • 13.4.4 INDIA
      • 13.4.4.1 Favorable government initiatives for R&D investments to drive market
    • 13.4.5 REST OF ASIA PACIFIC
  • 13.5 LATIN AMERICA
    • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 13.5.2 BRAZIL
      • 13.5.2.1 AI initiatives to drive healthcare innovation and accessibility
    • 13.5.3 MEXICO
      • 13.5.3.1 AI to revolutionize healthcare delivery and outcomes, focusing on accessibility, efficiency, and innovation
    • 13.5.4 REST OF LATIN AMERICA
  • 13.6 MIDDLE EAST & AFRICA
    • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 13.6.2 GCC COUNTRIES
      • 13.6.2.1 AI-driven innovations and rise in healthcare investments to propel market growth
    • 13.6.3 REST OF THE MIDDLE EAST & AFRICA

14 COMPETITIVE LANDSCAPE

  • 14.1 INTRODUCTION
  • 14.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET
  • 14.3 REVENUE ANALYSIS, 2020-2024
  • 14.4 MARKET SHARE ANALYSIS, 2024
    • 14.4.1 RANKING OF KEY MARKET PLAYERS
  • 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 14.5.1 STARS
    • 14.5.2 EMERGING LEADERS
    • 14.5.3 PERVASIVE PLAYERS
    • 14.5.4 PARTICIPANTS
    • 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 14.5.5.1 Company footprint
      • 14.5.5.2 Regional footprint
      • 14.5.5.3 Application footprint
      • 14.5.5.4 Tool footprint
      • 14.5.5.5 Function footprint
      • 14.5.5.6 Offering footprint
      • 14.5.5.7 Deployment footprint
      • 14.5.5.8 End-user footprint
  • 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 14.6.1 PROGRESSIVE COMPANIES
    • 14.6.2 RESPONSIVE COMPANIES
    • 14.6.3 DYNAMIC COMPANIES
    • 14.6.4 STARTING BLOCKS
    • 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 14.6.5.1 Detailed list of key startups/SMEs
      • 14.6.5.2 Company footprint (startups/SMEs)
  • 14.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 14.7.1 FINANCIAL METRICS
    • 14.7.2 COMPANY VALUATION
  • 14.8 BRAND/PRODUCT COMPARISON
  • 14.9 COMPETITIVE SCENARIO
    • 14.9.1 PRODUCT LAUNCHES
    • 14.9.2 DEALS
    • 14.9.3 OTHER DEVELOPMENTS

15 COMPANY PROFILES

  • 15.1 KEY PLAYERS
    • 15.1.1 KONINKLIJKE PHILIPS N.V.
      • 15.1.1.1 Business overview
      • 15.1.1.2 Products & services offered
      • 15.1.1.3 Recent developments
        • 15.1.1.3.1 Product launches
        • 15.1.1.3.2 Deals
        • 15.1.1.3.3 Expansions
        • 15.1.1.3.4 Other developments
      • 15.1.1.4 MnM view
        • 15.1.1.4.1 Right to win
        • 15.1.1.4.2 Strategic choices
        • 15.1.1.4.3 Weaknesses & competitive threats
    • 15.1.2 MICROSOFT CORPORATION
      • 15.1.2.1 Business overview
      • 15.1.2.2 Products & services offered
      • 15.1.2.3 Recent developments
        • 15.1.2.3.1 Product launches
        • 15.1.2.3.2 Deals
      • 15.1.2.4 MnM view
        • 15.1.2.4.1 Right to win
        • 15.1.2.4.2 Strategic choices
        • 15.1.2.4.3 Weaknesses & competitive threats
    • 15.1.3 NVIDIA CORPORATION
      • 15.1.3.1 Business overview
      • 15.1.3.2 Products & services offered
      • 15.1.3.3 Recent developments
        • 15.1.3.3.1 Product launches
        • 15.1.3.3.2 Deals
      • 15.1.3.4 MnM view
        • 15.1.3.4.1 Right to win
        • 15.1.3.4.2 Strategic choices
        • 15.1.3.4.3 Weaknesses & competitive threats
    • 15.1.4 SIEMENS HEALTHINEERS AG
      • 15.1.4.1 Business overview
      • 15.1.4.2 Products & services offered
      • 15.1.4.3 Recent developments
        • 15.1.4.3.1 Product launches & enhancements
        • 15.1.4.3.2 Deals
        • 15.1.4.3.3 Other developments
      • 15.1.4.4 MnM view
        • 15.1.4.4.1 Right to win
        • 15.1.4.4.2 Strategic choices
        • 15.1.4.4.3 Weaknesses & competitive threats
    • 15.1.5 GE HEALTHCARE
      • 15.1.5.1 Business overview
      • 15.1.5.2 Products & services offered
      • 15.1.5.3 Recent developments
        • 15.1.5.3.1 Deals
        • 15.1.5.3.2 Other developments
      • 15.1.5.4 MnM view
        • 15.1.5.4.1 Right to win
        • 15.1.5.4.2 Strategic choices
        • 15.1.5.4.3 Weaknesses & competitive threats
    • 15.1.6 EPIC SYSTEMS CORPORATION
      • 15.1.6.1 Business overview
      • 15.1.6.2 Products & services offered
      • 15.1.6.3 Recent developments
        • 15.1.6.3.1 Deals
    • 15.1.7 ORACLE CORPORATION
      • 15.1.7.1 Business overview
      • 15.1.7.2 Products & services offered
      • 15.1.7.3 Recent developments
        • 15.1.7.3.1 Product launches
        • 15.1.7.3.2 Deals
        • 15.1.7.3.3 Expansions
    • 15.1.8 VERADIGM INC.
      • 15.1.8.1 Business overview
      • 15.1.8.2 Products & services offered
      • 15.1.8.3 Recent developments
        • 15.1.8.3.1 Deals
    • 15.1.9 AMAZON WEB SERVICES, INC.
      • 15.1.9.1 Business overview
      • 15.1.9.2 Products & services offered
      • 15.1.9.3 Recent developments
        • 15.1.9.3.1 Product launches
        • 15.1.9.3.2 Deals
        • 15.1.9.3.3 Expansions
    • 15.1.10 MERATIVE
      • 15.1.10.1 Business overview
      • 15.1.10.2 Products & services offered
      • 15.1.10.3 Recent developments
        • 15.1.10.3.1 Product launches
        • 15.1.10.3.2 Deals
    • 15.1.11 IBM
      • 15.1.11.1 Business overview
      • 15.1.11.2 Products & services offered
      • 15.1.11.3 Recent developments
        • 15.1.11.3.1 Deals
    • 15.1.12 MEDTRONIC
      • 15.1.12.1 Business overview
      • 15.1.12.2 Products & services offered
      • 15.1.12.3 Recent developments
        • 15.1.12.3.1 Product launches
        • 15.1.12.3.2 Deals
    • 15.1.13 GOOGLE
      • 15.1.13.1 Business overview
      • 15.1.13.2 Products & services offered
      • 15.1.13.3 Recent developments
        • 15.1.13.3.1 Product launches
        • 15.1.13.3.2 Deals
        • 15.1.13.3.3 Other developments
    • 15.1.14 SOPHIA GENETICS
      • 15.1.14.1 Business overview
      • 15.1.14.2 Products & services offered
      • 15.1.14.3 Recent developments
        • 15.1.14.3.1 Product launches
        • 15.1.14.3.2 Deals
        • 15.1.14.3.3 Other developments
    • 15.1.15 JOHNSON & JOHNSON SERVICES, INC.
      • 15.1.15.1 Business overview
      • 15.1.15.2 Products & services offered
      • 15.1.15.3 Recent developments
        • 15.1.15.3.1 Other developments
        • 15.1.15.3.2 Deals
    • 15.1.16 TEMPUS AI, INC.
      • 15.1.16.1 Business overview
      • 15.1.16.2 Products & services offered
      • 15.1.16.3 Recent developments
        • 15.1.16.3.1 Product launches
        • 15.1.16.3.2 Deals
    • 15.1.17 CONCERTAI
      • 15.1.17.1 Business overview
      • 15.1.17.2 Products & services offered
      • 15.1.17.3 Recent developments
        • 15.1.17.3.1 Product launches
        • 15.1.17.3.2 Deals
    • 15.1.18 SOLVENTUM CORPORATION
      • 15.1.18.1 Business overview
      • 15.1.18.2 Products & services offered
      • 15.1.18.3 Recent developments
        • 15.1.18.3.1 Deals
        • 15.1.18.3.2 Other developments
    • 15.1.19 COGNIZANT
      • 15.1.19.1 Business overview
      • 15.1.19.2 Products & services offered
      • 15.1.19.3 Recent developments
        • 15.1.19.3.1 Product launches
        • 15.1.19.3.2 Deals
    • 15.1.20 VIZ.AI, INC.
      • 15.1.20.1 Business overview
      • 15.1.20.2 Products & services offered
      • 15.1.20.3 Recent developments
        • 15.1.20.3.1 Product launches
        • 15.1.20.3.2 Deals
        • 15.1.20.3.3 Other developments
    • 15.1.21 RIVERAIN TECHNOLOGIES
      • 15.1.21.1 Business overview
      • 15.1.21.2 Products & services offered
      • 15.1.21.3 Recent developments
        • 15.1.21.3.1 Deals
  • 15.2 OTHER PLAYERS
    • 15.2.1 QVENTUS
    • 15.2.2 QURE.AI
    • 15.2.3 ATOMWISE INC.
    • 15.2.4 ENLITIC
    • 15.2.5 SEGMED

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 INCLUSIONS & EXCLUSIONS
  • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 3 STUDY ASSUMPTIONS
  • TABLE 4 AI IN HEALTHCARE MARKET: RISK ASSESSMENT
  • TABLE 5 AI IN HEALTHCARE MARKET: IMPACT ANALYSIS
  • TABLE 6 COMPANIES AND THEIR ROLES IN AI IN HEALTHCARE ECOSYSTEM
  • TABLE 7 KEY PATENTS IN AI IN HEALTHCARE MARKET
  • TABLE 8 AI IN HEALTHCARE MARKET: LIST OF CONFERENCES & EVENTS, 2025-2026
  • TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 NORTH AMERICA
  • TABLE 13 EUROPE
  • TABLE 14 ASIA PACIFIC
  • TABLE 15 MIDDLE EAST & AFRICA
  • TABLE 16 LATIN AMERICA
  • TABLE 17 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 19 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 20 UNMET NEEDS IN AI IN HEALTHCARE MARKET
  • TABLE 21 END-USER EXPECTATIONS IN AI IN HEALTHCARE MARKET
  • TABLE 22 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 23 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR AI IN REMOTE PATIENT MONITORING
  • TABLE 24 EXPECTED CHANGE IN PRICES AND LIKELY IMPACT ON END-USE MARKET DUE TO TARIFF IMPACT
  • TABLE 1 AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 2 AI IN HEALTHCARE MARKET FOR INTEGRATED SOLUTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 3 AI IN HEALTHCARE MARKET FOR NICHE/POINT SOLUTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 4 AI IN HEALTHCARE MARKET FOR AI TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 5 AI IN HEALTHCARE MARKET FOR SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 6 AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 7 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 8 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 9 AI IN HEALTHCARE MARKET FOR PRE-SCREENING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 10 AI IN HEALTHCARE MARKET FOR IVD, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 11 AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 12 AI IN HEALTHCARE MARKET FOR IMMUNOASSAYS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 13 AI IN HEALTHCARE MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 14 AI IN HEALTHCARE MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 15 AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 16 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS & INTERPRETATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 17 AI IN HEALTHCARE MARKET FOR BIOMARKER DISCOVERY & ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 18 AI IN HEALTHCARE MARKET FOR OTHER IVD APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 19 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 20 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 21 AI IN HEALTHCARE MARKET FOR DISEASE INTERPRETATION & REPORT ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 22 AI IN HEALTHCARE MARKET FOR IMAGE CAPTIONING & ANNOTATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 23 AI IN HEALTHCARE MARKET FOR IMAGE RECONSTRUCTION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 24 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 25 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 26 AI IN HEALTHCARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2023-2030 (USD MILLION)
  • TABLE 27 AI IN HEALTHCARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2023-2030 (USD MILLION)
  • TABLE 28 AI IN HEALTHCARE MARKET FOR X-RAY IMAGING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 29 AI IN HEALTHCARE MARKET FOR ULTRASOUND, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 30 AI IN HEALTHCARE MARKET FOR NUCLEAR IMAGING (PET & SPECT), BY REGION, 2023-2030 (USD MILLION)
  • TABLE 31 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING MODALITIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 32 AI IN HEALTHCARE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 33 AI IN HEALTHCARE MARKET FOR DRUG ALLERGY ALERTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 34 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 36 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 37 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 38 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 AI IN HEALTHCARE MARKET FOR PRECISION MEDICINE & GENOMIC ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 40 AI IN HEALTHCARE MARKET FOR PREDICTIVE MODELS FOR TREATMENT RESPONSE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 41 AI IN HEALTHCARE MARKET FOR TREATMENT RECOMMENDATION SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 43 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 AI IN HEALTHCARE MARKET FOR DRUG RESPONSE PREDICTION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 45 AI IN HEALTHCARE MARKET FOR DOSING & ADMINISTRATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 AI IN HEALTHCARE MARKET FOR OTHER PHARMACOLOGICAL THERAPY FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 47 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 48 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 49 AI IN HEALTHCARE MARKET FOR PREOPERATIVE IMAGING & 3D MODELING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 50 AI IN HEALTHCARE MARKET FOR INTRAOPERATIVE GUIDANCE & ROBOTICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 51 AI IN HEALTHCARE MARKET FOR POSTOPERATIVE ANALYSIS & RECOVERY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 53 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 54 AI IN HEALTHCARE MARKET FOR MOTION SYNCHRONIZATION & AUTO CONTOURING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 55 AI IN HEALTHCARE MARKET FOR REAL-TIME ADAPTIVE TREATMENT DELIVERY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 56 AI IN HEALTHCARE MARKET FOR RESPONSE ASSESSMENT & QUALITY ASSURANCE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 57 AI IN HEALTHCARE MARKET FOR OTHER RADIATION THERAPY FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 59 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 60 AI IN HEALTHCARE MARKET FOR VIRTUAL COUNSELING & CHATBOTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 61 AI IN HEALTHCARE MARKET FOR PROGRESS MONITORING & FEEDBACK, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 62 AI IN HEALTHCARE MARKET FOR FOLLOW-UP & LONG-TERM SUPPORT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 63 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 65 AI IN HEALTHCARE MARKET FOR REAL-TIME PATIENT DATA MONITORING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 66 AI IN HEALTHCARE MARKET FOR RESPONSE & SIDE-EFFECT PREDICTION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 67 AI IN HEALTHCARE MARKET FOR RELAPSE PREDICTION & LONG-TERM MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 68 AI IN HEALTHCARE MARKET FOR OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 69 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 70 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 71 AI IN HEALTHCARE MARKET FOR SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 72 AI IN HEALTHCARE MARKET FOR TELEHEALTH & REMOTE PATIENT MONITORING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 73 AI IN HEALTHCARE MARKET FOR HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 74 AI IN HEALTHCARE MARKET FOR MEDICATION REMINDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 75 AI IN HEALTHCARE MARKET FOR PATIENT EDUCATION & EMPOWERMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 76 AI IN HEALTHCARE MARKET FOR OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 77 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 78 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 79 AI IN HEALTHCARE MARKET FOR RECURRENCE MONITORING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 80 AI IN HEALTHCARE MARKET FOR LONG-TERM OUTCOME PREDICTION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 81 AI IN HEALTHCARE MARKET FOR MENTAL HEALTH & SUPPORT SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 82 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 83 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 84 AI IN HEALTHCARE MARKET FOR EPRESCRIBING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 85 AI IN HEALTHCARE MARKET FOR MEDICATION MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 86 AI IN HEALTHCARE MARKET FOR PHARMACY AUDIT & ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 87 AI IN HEALTHCARE MARKET FOR OTHER PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 88 AI IN HEALTHCARE MARKET FOR DATA MANAGEMENT & ANALYTICS FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 89 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 90 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 91 AI IN HEALTHCARE MARKET FOR PATIENT REGISTRATION & SCHEDULING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 92 AI IN HEALTHCARE MARKET FOR PATIENT ELIGIBILITY & AUTHORIZATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 93 AI IN HEALTHCARE MARKET FOR BILLING & CLAIMS MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 94 AI IN HEALTHCARE MARKET FOR WORKFORCE MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 95 AI IN HEALTHCARE MARKET FOR SUPPLY CHAIN & INVENTORY MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 96 AI IN HEALTHCARE MARKET FOR COMPLIANCE & DOCUMENTATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 97 AI IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 98 AI IN HEALTHCARE MARKET FOR ASSET MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 99 AI IN HEALTHCARE MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 100 AI IN HEALTHCARE MARKET FOR FRAUD DETECTION & RISK MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 101 AI IN HEALTHCARE MARKET FOR CYBERSECURITY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 102 AI IN HEALTHCARE MARKET FOR OTHER ADMINISTRATIVE FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 103 AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 104 AI IN HEALTHCARE MARKET FOR CLINICAL APPLICATIONS, BY REGION, CAGR (2025-2030)
  • TABLE 105 AI IN HEALTHCARE MARKET FOR NON-CLINICAL APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 106 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 107 AI IN HEALTHCARE MARKET FOR ON-PREMISE MODELS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 108 AI IN HEALTHCARE MARKET FOR CLOUD-BASED MODELS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 109 AI IN HEALTHCARE MARKET FOR HYBRID MODELS, BY REGION, CAGR (2025-2030)
  • TABLE 110 AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 111 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 113 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 115 AI IN HEALTHCARE MARKET FOR CONVOLUTIONAL NEURAL NETWORKS (CNN), BY REGION, 2023-2030 (USD MILLION)
  • TABLE 116 AI IN HEALTHCARE MARKET FOR RECURRENT NEURAL NETWORKS (RNN), BY REGION, 2023-2030 (USD MILLION)
  • TABLE 117 AI IN HEALTHCARE MARKET FOR GENERATIVE ADVERSARIAL NETWORKS (GAN), BY REGION, 2023-2030 (USD MILLION)
  • TABLE 118 AI IN HEALTHCARE MARKET FOR GRAPH NEURAL NETWORKS (GNN), BY REGION, 2023-2030 (USD MILLION)
  • TABLE 119 AI IN HEALTHCARE MARKET FOR OTHER DEEP LEARNING TOOLS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 120 AI IN HEALTHCARE MARKET FOR SUPERVISED LEARNING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 121 AI IN HEALTHCARE MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 122 AI IN HEALTHCARE MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 123 AI IN HEALTHCARE MARKET FOR OTHER MACHINE LEARNING TOOLS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 124 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 125 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY REGION, 2023-2030 (USD MILLION)
  • TABLE 126 AI IN HEALTHCARE MARKET FOR SENTIMENT ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 127 AI IN HEALTHCARE MARKET FOR PATTERN & IMAGE RECOGNITION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 128 AI IN HEALTHCARE MARKET FOR AUTO CODING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 129 AI IN HEALTHCARE MARKET FOR CLASSIFICATION & CATEGORIZATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 130 AI IN HEALTHCARE MARKET FOR TEXT ANALYTICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 131 AI IN HEALTHCARE MARKET FOR SPEECH RECOGNITION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 132 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 133 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 134 AI IN HEALTHCARE MARKET FOR DEVICE CONTEXT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 135 AI IN HEALTHCARE MARKET FOR USER CONTEXT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 136 AI IN HEALTHCARE MARKET FOR PHYSICAL CONTEXT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 137 AI IN HEALTHCARE MARKET FOR GENERATIVE AI, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 138 AI IN HEALTHCARE MARKET FOR COMPUTER VISION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 139 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 140 AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 141 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 143 AI IN HEALTHCARE MARKET FOR HOSPITALS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 144 AI IN HEALTHCARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 145 AI IN HEALTHCARE MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 146 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 147 AI IN HEALTHCARE MARKET FOR PHARMACIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 148 AI IN HEALTHCARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 149 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 150 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 151 AI IN HEALTHCARE MARKET FOR PUBLIC PAYERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 152 AI IN HEALTHCARE MARKET FOR PRIVATE PAYERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 153 AI IN HEALTHCARE MARKET FOR PATIENTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 154 AI IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 155 AI IN HEALTHCARE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 156 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 157 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 158 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 159 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 160 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 161 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 162 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 163 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 164 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 165 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 166 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 167 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 170 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 172 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 173 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 174 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 175 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 176 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 177 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 178 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 179 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 180 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 181 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 182 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 183 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 184 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 185 US: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 186 US: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 187 US: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 US: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 189 US: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 190 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 191 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 192 US: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 193 US: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 194 US: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 195 US: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 US: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 197 US: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 US: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 199 US: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 200 US: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 201 US: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 202 US: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 203 US: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 204 US: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 205 US: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 206 US: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 207 US: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 208 US: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 US: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 US: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 211 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 213 CANADA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 214 CANADA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 215 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 216 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 217 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 218 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 219 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 220 CANADA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 221 CANADA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 222 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 223 CANADA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 224 CANADA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 CANADA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 CANADA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 CANADA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 228 CANADA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 229 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 230 CANADA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 CANADA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 232 CANADA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 233 CANADA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 234 CANADA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 235 CANADA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 236 CANADA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 237 CANADA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 238 CANADA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 239 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 240 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 EUROPE: AI IN HEALTHCARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 242 EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 243 EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 244 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 245 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 246 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 247 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 248 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 249 EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 251 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 252 EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 253 EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 254 EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 256 EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 257 EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 258 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 259 EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 260 EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 261 EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 262 EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 263 EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 264 EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 265 EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 266 EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 268 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 269 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 270 GERMANY: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 271 GERMANY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 272 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 273 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 274 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 275 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 276 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 277 GERMANY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 278 GERMANY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 279 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 280 GERMANY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 281 GERMANY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 282 GERMANY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 283 GERMANY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 284 GERMANY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 285 GERMANY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 286 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 287 GERMANY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 288 GERMANY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 289 GERMANY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 290 GERMANY: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 291 GERMANY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 292 GERMANY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 293 GERMANY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 294 GERMANY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 295 GERMANY: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 296 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 297 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 298 UK: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 299 UK: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 300 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 301 UK: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 302 UK: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 303 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 304 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 305 UK: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 306 UK: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 307 UK: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 308 UK: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 309 UK: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 310 UK: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 311 UK: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 312 UK: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 313 UK: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 314 UK: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 315 UK: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 316 UK: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 317 UK: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 318 UK: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 319 UK: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 320 UK: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 321 UK: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 322 UK: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 323 UK: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 324 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 325 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 326 FRANCE: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 327 FRANCE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 328 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 329 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 330 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 331 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 332 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 333 FRANCE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 334 FRANCE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 335 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 336 FRANCE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 337 FRANCE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 338 FRANCE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 339 FRANCE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 340 FRANCE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 341 FRANCE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 342 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 343 FRANCE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 344 FRANCE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 345 FRANCE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 346 FRANCE: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 347 FRANCE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 348 FRANCE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 349 FRANCE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 350 FRANCE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 351 FRANCE: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 352 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 353 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 354 ITALY: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 355 ITALY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 356 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 357 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 358 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 359 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 360 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 361 ITALY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 362 ITALY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 363 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 364 ITALY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 365 ITALY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 366 ITALY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 367 ITALY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 368 ITALY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 369 ITALY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 370 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 371 ITALY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 372 ITALY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 373 ITALY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 374 ITALY: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 375 ITALY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 376 ITALY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 377 ITALY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 378 ITALY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 379 ITALY: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 380 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 381 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 382 SPAIN: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 383 SPAIN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 384 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 385 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 386 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 387 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 388 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 389 SPAIN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 390 SPAIN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 391 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 392 SPAIN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 393 SPAIN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 394 SPAIN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 395 SPAIN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 396 SPAIN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 397 SPAIN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 398 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 399 SPAIN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 400 SPAIN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 401 SPAIN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 402 SPAIN: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 403 SPAIN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 404 SPAIN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 405 SPAIN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 406 SPAIN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 407 SPAIN: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 408 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 409 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 410 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 411 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 412 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 413 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 414 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 415 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 416 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 417 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 418 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 419 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 420 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 421 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 422 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 423 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 424 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 425 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 426 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 427 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 428 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 429 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 430 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 431 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 432 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 433 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 434 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 435 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 436 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 437 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 438 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 439 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 440 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 441 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 442 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 443 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 444 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 445 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 446 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 447 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 448 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 449 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 450 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 451 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 452 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 453 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 454 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 455 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 456 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 457 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 458 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 459 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 460 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 461 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 462 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 463 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 464 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 465 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 466 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 467 CHINA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 468 CHINA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 469 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 470 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 471 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 472 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 473 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 474 CHINA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 475 CHINA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 476 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 477 CHINA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 478 CHINA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 479 CHINA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 480 CHINA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 481 CHINA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 482 CHINA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 483 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 484 CHINA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 485 CHINA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 486 CHINA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 487 CHINA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 488 CHINA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 489 CHINA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 490 CHINA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 491 CHINA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 492 CHINA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 493 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 494 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 495 JAPAN: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 496 JAPAN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 497 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 498 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 499 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 500 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 501 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 502 JAPAN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 503 JAPAN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 504 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 505 JAPAN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 506 JAPAN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 507 JAPAN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 508 JAPAN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 509 JAPAN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 510 JAPAN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 511 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 512 JAPAN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 513 JAPAN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 514 JAPAN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 515 JAPAN: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 516 JAPAN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 517 JAPAN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 518 JAPAN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 519 JAPAN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 520 JAPAN: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 521 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 522 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 523 INDIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 524 INDIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 525 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 526 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 527 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 528 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 529 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 530 INDIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 531 INDIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 532 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 533 INDIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 534 INDIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 535 INDIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 536 INDIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 537 INDIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 538 INDIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 539 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 540 INDIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 541 INDIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 542 INDIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 543 INDIA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 544 INDIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 545 INDIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 546 INDIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 547 INDIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 548 INDIA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 549 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 550 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 551 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 552 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 553 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 554 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 555 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 556 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 557 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 558 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 559 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 560 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 561 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 562 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 563 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 564 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 565 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 566 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 567 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 568 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 569 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 570 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 571 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 572 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 573 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 574 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 575 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 576 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 577 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 578 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 579 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 580 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 581 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 582 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 583 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 584 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 585 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 586 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 587 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 588 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 589 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 590 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 591 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 592 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 593 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 594 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 595 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 596 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 597 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 598 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 599 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 600 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 601 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 602 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 603 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 604 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 605 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 606 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 607 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 608 BRAZIL: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 609 BRAZIL: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 610 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 611 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 612 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 613 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 614 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 615 BRAZIL: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 616 BRAZIL: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 617 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 618 BRAZIL: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 619 BRAZIL: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 620 BRAZIL: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 621 BRAZIL: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 622 BRAZIL: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 623 BRAZIL: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 624 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 625 BRAZIL: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 626 BRAZIL: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 627 BRAZIL: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 628 BRAZIL: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 629 BRAZIL: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 630 BRAZIL: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 631 BRAZIL: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 632 BRAZIL: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 633 BRAZIL: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 634 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 635 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 636 MEXICO: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 637 MEXICO: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 638 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 639 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 640 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 641 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 642 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 643 MEXICO: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 644 MEXICO: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 645 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 646 MEXICO: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 647 MEXICO: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 648 MEXICO: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 649 MEXICO: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 650 MEXICO: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 651 MEXICO: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 652 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 653 MEXICO: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 654 MEXICO: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 655 MEXICO: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 656 MEXICO: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 657 MEXICO: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 658 MEXICO: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 659 MEXICO: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 660 MEXICO: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 661 MEXICO: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 662 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 663 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 664 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 665 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 666 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 667 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 668 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 669 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 670 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 671 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 672 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 673 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 674 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 675 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 676 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 677 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 678 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 679 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 680 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 681 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 682 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 683 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 684 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 685 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 686 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 687 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 688 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 689 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 690 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 691 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 692 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 693 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 694 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 695 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 696 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 697 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 698 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 699 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 700 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 701 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 702 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 703 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 704 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 705 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 706 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 707 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 708 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 709 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 710 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 711 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 712 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 713 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 714 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 715 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 716 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 717 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 718 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 719 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 720 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 721 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 722 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 723 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 724 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 725 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 726 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 727 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 728 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 729 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 730 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 731 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 732 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 733 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 734 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 735 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 736 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 737 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 738 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 739 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 740 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 741 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 742 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 743 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 744 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 745 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 746 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 747 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 748 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 749 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 750 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 751 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 752 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 753 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 754 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 755 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 756 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 757 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 758 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 759 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 760 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 761 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 762 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 763 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 764 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 765 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 766 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 767 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 768 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 769 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION)
  • TABLE 770 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 771 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 772 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 773 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 774 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 775 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 776 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 777 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, JANUARY 2021-APRIL 2025
  • TABLE 778 AI IN HEALTHCARE MARKET SHARE ANALYSIS, 2024
  • TABLE 779 AI IN HEALTHCARE MARKET: REGIONAL FOOTPRINT, 2024
  • TABLE 780 AI IN HEALTHCARE MARKET: APPLICATION FOOTPRINT, 2024
  • TABLE 781 AI IN HEALTHCARE MARKET: TOOL FOOTPRINT, 2024
  • TABLE 782 AI IN HEALTHCARE MARKET: FUNCTION FOOTPRINT, 2024
  • TABLE 783 AI IN HEALTHCARE MARKET: OFFERING FOOTPRINT, 2024
  • TABLE 784 AI IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT, 2024
  • TABLE 785 AI IN HEALTHCARE MARKET: END-USER FOOTPRINT, 2024
  • TABLE 786 AI IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/ SME PLAYERS, 2024
  • TABLE 787 AI IN HEALTHCARE MARKET: APPLICATION AND REGIONAL FOOTPRINT (STARTUPS/SMES), 2024
  • TABLE 788 AI IN HEALTHCARE MARKET: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
  • TABLE 789 AI IN HEALTHCARE MARKET: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 790 AI IN HEALTHCARE MARKET: OTHER DEVELOPMENTS, JANUARY 2021-APRIL 2025
  • TABLE 791 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 792 KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED
  • TABLE 793 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
  • TABLE 794 KONINKLIJKE PHILIPS N.V.: DEALS
  • TABLE 795 KONINKLIJKE PHILIPS N.V.: EXPANSIONS
  • TABLE 796 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS
  • TABLE 797 MICROSOFT CORPORATION: COMPANY OVERVIEW
  • TABLE 798 MICROSOFT CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 799 MICROSOFT CORPORATION: PRODUCT LAUNCHES
  • TABLE 800 MICROSOFT CORPORATION: DEALS
  • TABLE 801 NVIDIA CORPORATION: COMPANY OVERVIEW
  • TABLE 802 NVIDIA CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 803 NVIDIA CORPORATION: PRODUCT LAUNCHES
  • TABLE 804 NVIDIA CORPORATION: DEALS
  • TABLE 805 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 806 SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED
  • TABLE 807 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & ENHANCEMENTS
  • TABLE 808 SIEMENS HEALTHINEERS AG: DEALS
  • TABLE 809 SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS
  • TABLE 810 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 811 GE HEALTHCARE: PRODUCTS & SERVICES OFFERED
  • TABLE 812 GE HEALTHCARE: DEALS
  • TABLE 813 GE HEALTHCARE: OTHER DEVELOPMENTS
  • TABLE 814 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 815 EPIC SYSTEMS CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 816 EPIC SYSTEMS CORPORATION: DEALS
  • TABLE 817 ORACLE CORPORATION: COMPANY OVERVIEW
  • TABLE 818 ORACLE: PRODUCTS & SERVICES OFFERED
  • TABLE 819 ORACLE: PRODUCT LAUNCHES
  • TABLE 820 ORACLE CORPORATION: DEALS
  • TABLE 821 ORACLE: EXPANSIONS
  • TABLE 822 VERADIGM LLC: COMPANY OVERVIEW
  • TABLE 823 VERADIGM LLC: PRODUCTS & SERVICES OFFERED
  • TABLE 824 VERADIGM LLC: DEALS
  • TABLE 825 AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 826 AMAZON WEB SERVICES, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 827 AMAZON WEB SERVICES, INC.: PRODUCT LAUNCHES
  • TABLE 828 AMAZON WEB SERVICES, INC.: DEALS
  • TABLE 829 AMAZON WEB SERVICES, INC.: EXPANSIONS
  • TABLE 830 MERATIVE: COMPANY OVERVIEW
  • TABLE 831 MERATIVE: PRODUCTS & SERVICES OFFERED
  • TABLE 832 MERATIVE: PRODUCT LAUNCHES
  • TABLE 833 MERATIVE: DEALS
  • TABLE 834 IBM: COMPANY OVERVIEW
  • TABLE 835 IBM: PRODUCTS & SERVICES OFFERED
  • TABLE 836 IBM: DEALS
  • TABLE 837 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 838 MEDTRONIC: PRODUCTS & SERVICES OFFERED
  • TABLE 839 MEDTRONIC: PRODUCT LAUNCHES
  • TABLE 840 MEDTRONIC: DEALS
  • TABLE 841 GOOGLE: COMPANY OVERVIEW
  • TABLE 842 GOOGLE: PRODUCTS & SERVICES OFFERED
  • TABLE 843 GOOGLE: PRODUCT LAUNCHES
  • TABLE 844 GOOGLE: DEALS
  • TABLE 845 GOOGLE: OTHER DEVELOPMENTS
  • TABLE 846 SOPHIA GENETICS: COMPANY OVERVIEW
  • TABLE 847 SOPHIA GENETICS: PRODUCTS & SERVICES OFFERED
  • TABLE 848 SOPHIA GENETICS: PRODUCT LAUNCHES
  • TABLE 849 SOPHIA GENETICS: DEALS
  • TABLE 850 SOPHIA GENETICS: OTHER DEVELOPMENTS
  • TABLE 851 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 852 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 853 JOHNSON & JOHNSON SERVICES, INC.: OTHER DEVELOPMENTS
  • TABLE 854 JOHNSON & JOHNSON SERVICES, INC.: DEALS
  • TABLE 855 TEMPUS AI, INC. COMPANY OVERVIEW
  • TABLE 856 TEMPUS AI, INC. PRODUCTS & SERVICES OFFERED
  • TABLE 857 TEMPUS AI, INC.: PRODUCT LAUNCHES
  • TABLE 858 TEMPUS AI, INC. DEALS
  • TABLE 859 CONCERTAI: COMPANY OVERVIEW
  • TABLE 860 CONCERTAI: PRODUCTS & SERVICES OFFERED
  • TABLE 861 CONCERTAI: PRODUCT LAUNCHES
  • TABLE 862 CONCERTAI: DEALS
  • TABLE 863 SOLVENTUM CORPORATION: COMPANY OVERVIEW
  • TABLE 864 SOLVENTUM CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 865 SOLVENTUM CORPORATION: DEALS
  • TABLE 866 SOLVENTUM CORPORATION: OTHER DEVELOPMENTS
  • TABLE 867 COGNIZANT: COMPANY OVERVIEW
  • TABLE 868 COGNIZANT: PRODUCTS & SERVICES OFFERED
  • TABLE 869 COGNIZANT: PRODUCT LAUNCHES
  • TABLE 870 COGNIZANT: DEALS
  • TABLE 871 VIZ.AI, INC.: COMPANY OVERVIEW
  • TABLE 872 VIZ.AI, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 873 VIZ.AI, INC.: PRODUCT LAUNCHES
  • TABLE 874 VIZ.AI, INC.: DEALS
  • TABLE 875 VIZ.AI, INC.: OTHER DEVELOPMENTS
  • TABLE 876 RIVERAIN TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 877 RIVERAIN TECHNOLOGIES: PRODUCTS & SERVICES OFFERED
  • TABLE 878 RIVERAIN TECHNOLOGIES: DEALS

List of Figures

  • FIGURE 1 AI IN HEALTHCARE MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 YEARS CONSIDERED
  • FIGURE 3 RESEARCH DESIGN
  • FIGURE 4 KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 PRIMARY SOURCES
  • FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 9 BOTTOM-UP APPROACH: END-USER SPENDING ON AI IN HEALTHCARE
  • FIGURE 10 AI IN HEALTHCARE MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES, 2025-2030
  • FIGURE 11 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 TOP-DOWN APPROACH
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 AI IN HEALTHCARE MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 AI IN HEALTHCARE MARKET, BY FUNCTION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 AI IN HEALTHCARE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 AI IN HEALTHCARE MARKET, BY TOOL, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 AI IN HEALTHCARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 AI IN HEALTHCARE MARKET: REGIONS COVERED
  • FIGURE 21 RISING NEED FOR EARLY DISEASE DETECTION TO DRIVE MARKET
  • FIGURE 22 INTEGRATED SOLUTIONS AND JAPAN LED RESPECTIVE SEGMENTS IN ASIA PACIFIC IN 2024
  • FIGURE 23 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 24 NORTH AMERICA TO DOMINATE AI IN HEALTHCARE MARKET DURING FORECAST PERIOD
  • FIGURE 25 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 26 AI IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 27 DATA BREACHES IN HEALTHCARE SECTOR, 2019-2023
  • FIGURE 28 CHALLENGES ASSOCIATED WITH HEALTHCARE DATA INTEROPERABILITY
  • FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 30 AI IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 31 AI IN HEALTHCARE MARKET: ECOSYSTEM MAPPING
  • FIGURE 32 GLOBAL PATENT PUBLICATION TRENDS IN AI IN HEALTHCARE MARKET, 2017-2024
  • FIGURE 33 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR AI IN HEALTHCARE PATENTS, JANUARY 2017-DECEMBER 2024
  • FIGURE 34 TOP APPLICANTS FOR AI IN HEALTHCARE PATENTS (COUNTRY/REGION), JANUARY 2017-DECEMBER 2024
  • FIGURE 35 AI IN HEALTHCARE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 37 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 38 AI IN HEALTHCARE MARKET: INVESTMENT & FUNDING SCENARIO, 2024 (USD MILLION)
  • FIGURE 39 GEN AI USE CASES IN HEALTHCARE
  • FIGURE 40 INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 41 NORTH AMERICA: AI IN HEALTHCARE MARKET SNAPSHOT
  • FIGURE 42 ASIA PACIFIC: AI IN HEALTHCARE MARKET SNAPSHOT
  • FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2020-2024
  • FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2024
  • FIGURE 45 RANKING OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2024
  • FIGURE 46 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 47 AI IN HEALTHCARE MARKET: COMPANY FOOTPRINT, 2024
  • FIGURE 48 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 49 EV/EBITDA OF KEY VENDORS, 2025
  • FIGURE 50 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
  • FIGURE 51 AI IN HEALTHCARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 52 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)
  • FIGURE 53 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 54 NVIDIA CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 55 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)
  • FIGURE 56 GE HEALTHCARE: COMPANY SNAPSHOT (2024)
  • FIGURE 57 ORACLE CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 58 VERADIGM INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 59 AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 60 IBM: COMPANY SNAPSHOT (2024)
  • FIGURE 61 MEDTRONIC: COMPANY SNAPSHOT (2024)
  • FIGURE 62 GOOGLE: COMPANY SNAPSHOT (2024)
  • FIGURE 63 SOPHIA GENETICS: COMPANY SNAPSHOT (2024)
  • FIGURE 64 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 65 TEMPUS: COMPANY SNAPSHOT (2024)
  • FIGURE 66 SOLVENTUM CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 67 COGNIZANT: COMPANY SNAPSHOT (2024)